Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

0.9774
-0.0226-2.26%
Post-market: 1.000.0226+2.31%19:59 EDT
Volume:12.02M
Turnover:11.79M
Market Cap:330.87M
PE:-3.83
High:1.01
Open:1.01
Low:0.9601
Close:1.00
52wk High:2.73
52wk Low:0.9601
Shares:338.52M
Float Shares:327.56M
Volume Ratio:2.45
T/O Rate:3.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-19.98
PE(LYR):-4.32

Loading ...

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
May 12

H.C. Wainwright Keeps Their Buy Rating on Ocugen (OCGN)

TIPRANKS
·
May 11

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 08

Ocugen completes USD 115 million 6.75% convertible senior notes offering due 2034

Reuters
·
May 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Haemonetics (HAE), Scholar Rock Holding (SRRK) and Ocugen (OCGN)

TIPRANKS
·
May 08

Chardan Capital Remains a Buy on Ocugen (OCGN)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN), Vertex Pharmaceuticals (VRTX) and Solventum Corporation (SOLV)

TIPRANKS
·
May 06

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 06

BUZZ-Ocugen plunges after $115 million convertible bonds offering, bigger loss

Reuters
·
May 06

Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway

TIPRANKS
·
May 05

Ocugen Down Over 19%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Dow Jones
·
May 05

Ocugen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Ocugen reports Q1 EPS (6c), consensus (5c)

TIPRANKS
·
May 05

Gene therapy firm Ocugen's Q1 revenue beats, extends cash runway to 2028

Reuters
·
May 05

Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate

Benzinga Earnings
·
May 05

BRIEF-Ocugen, Inc. Announces Pricing Of $115 Million Of 6.75% Convertible Senior Notes

Reuters
·
May 05

BRIEF-Ocugen Q1 EPS USD -0.06

Reuters
·
May 05

Ocugen Provides Business Update with First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Ocugen prices USD 115 million 6.75% convertible senior notes due 2034

Reuters
·
May 05

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
May 05